Allergan has announced that it’s received approval from the U.S. Food and Drug Administration (FDA) to market NATRELLE INSPIRA Cohesive breast implants for women undergoing reconstruction, augmentation or revision surgery. The implants combine a high gel fill ratio and Allergan’s highly cohesive gel for customized results, and are available with both smooth and BIOCELL textured surfaces.
“NATRELLE INSPIRA Cohesive allows patients to get the same high gel fill ratio and fullness offered by the NATRELLE INSPIRA line of implants, with our highly cohesive, form-stable gel,” said David Nicholson, chief R&D officer at Allergan.
